LexaGene LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats The RT-PCR system was developed for veterinary diagnostic and food safety applications but is being tested for human pathogens under the cooperative R&D agreement. New Products Posted to GenomeWeb: SomaLogic, LGC SeraCare, LexaGene, More LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch The Beverly, Massachusetts-based firm noted that all revenue from its MiQLab was generated from US customers. LexaGene, Ethos Discovery to Develop Veterinary Infectious Disease Panels Ethos Discovery will offer consulting services for identifying relevant targets in each panel based on disease prevalence and alignment with LexaGene's MiQLab platform. LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2 Premium The MiQLab system can look for 27 different targets, allowing the detection of SARS-CoV-2 as well as the determination of specific variants. Sep 9, 2020 LexaGene Closes C$13.3M Funding Round Apr 3, 2020 LexaGene Shifts Gears to Prepare Viral RT-qPCR Panel for FDA Emergency Submission Oct 29, 2019 LexaGene Closes C$6.6M Financing Round Sep 27, 2019 In Brief This Week: 10x Genomics, Yourgene, HTG Molecular, GenScript, More Mar 29, 2019 LexaGene Closes C$2.8M Private Placement Mar 13, 2019 LexaGene Plans C$2M Private Placement Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.